This clinical trial is for patients with Advanced Prostate Cancer. The purpose of this study is to learn more about prostate cancer and:
Outline of the study includes a baseline (demographic data, epidemiological data, treatment history, clinical and pathology, patient reported outcomes and physician questionnaire), and follow-up visit for a minimum of three years (follow-up bloods, patient reported outcomes, physician questionnaire, and clinical follow-up data)
• Age 18 and older.
• Histological or cytological confirmation of prostate adenocarcinoma
• Detailed eligibility reviewed when you contact the study team.